Jeong Soo In, Kim Sung Hye
Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Republic of Korea.
Department of Pediatrics, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggido, Republic of Korea.
Clin Hypertens. 2024 Sep 1;30(1):23. doi: 10.1186/s40885-024-00278-5.
As childhood obesity rates increase worldwide, the prevalence of obesity-related hypertension is also on the rise. Obesity has been identified as a significant risk factor for hypertension in this age group. National Health Surveys and meta-analyses show increasing trends in obesity and pediatric hypertension in obese children. The diagnosis of hypertension in children involves percentiles relative to age, sex, and height, unlike in adults, where absolute values are considered. Elevated blood pressure (BP) in childhood is consistently associated with cardiovascular disease in adulthood, emphasizing the need for early detection and intervention. The pathogenesis of hypertension in obesity involves multiple factors, including increased sympathetic nervous system activity, activation of the renin-angiotensin-aldosterone system (RAAS), and renal compression due to fat accumulation. Obesity disrupts normal RAAS suppression and contributes to impaired pressure natriuresis and sodium retention, which are critical factors in the development of hypertension. Risk factors for hypertension in obesity include degree, duration, and distribution of obesity, patient age, hormonal changes during puberty, high-sodium diet, sedentary lifestyle, and socioeconomic status. Treatment involves lifestyle changes, with weight loss being crucial to lowering BP. Medications such as angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may be considered first, and surgical approaches may be an option for severe obesity, requiring tailored antihypertensive medications that consider individual pathophysiology to avoid exacerbating insulin resistance and dyslipidemia.
随着全球儿童肥胖率的上升,肥胖相关高血压的患病率也在增加。肥胖已被确定为该年龄组高血压的一个重要危险因素。国家健康调查和荟萃分析显示,肥胖儿童的肥胖和小儿高血压呈上升趋势。儿童高血压的诊断涉及相对于年龄、性别和身高的百分位数,这与成人不同,成人是考虑绝对值。儿童期血压升高与成年期心血管疾病始终相关,这强调了早期检测和干预的必要性。肥胖高血压的发病机制涉及多个因素,包括交感神经系统活动增加、肾素-血管紧张素-醛固酮系统(RAAS)激活以及脂肪堆积导致的肾压迫。肥胖会破坏正常的RAAS抑制,并导致压力性利钠和钠潴留受损,这些是高血压发展的关键因素。肥胖高血压的危险因素包括肥胖的程度、持续时间和分布、患者年龄、青春期的激素变化、高钠饮食、久坐不动的生活方式和社会经济地位。治疗包括生活方式改变,减肥对降低血压至关重要。血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂等药物可能首先被考虑,对于严重肥胖患者,手术方法可能是一种选择,需要根据个体病理生理学定制抗高血压药物,以避免加剧胰岛素抵抗和血脂异常。